| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
MacRogenics Inc (MGNX) has 8 insiders with recent SEC Form 4 filings, including 0 buys and 12 sells. MGNX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| VP | 152.2K | $697.2K | - | |
| Dir | 111.0K | $508.4K | - | |
| Dir | 0 | - | - | |
| CEO | 0 | - | - | |
| VP | 0 | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jul 1, 2015 | Cilinski Lynn | VP, Controller And Treasurer | Sale+OE | 6,921 | $37.15 | $257,115.15 | -41.9% | |
| Jul 1, 2015 | Wigginton Jon Marc | Sr VP, Clinical | Sale+OE | 5,000 | $37.15 | $185,750.00 | -100% | |
| Jun 30, 2015 | Bonvini Ezio72 | Senior VP, Research | Sale+OE | 6,497 | $38.07 | $247,340.79 | -15.0% | |
| Jun 24, 2015 | Bonvini Ezio72 | Senior VP, Research | Sell | 6,097 | $38.08 | $232,173.76 | -25.7% | |
| Jun 23, 2015 | Bonvini Ezio72 | Senior VP, Research | Sell | 13,054 | $38.14 | $497,879.56 | -35.5% | |
| Jun 15, 2015 | Cilinski Lynn | VP, Controller And Treasurer | Sale+OE | 10,700 | $35.00 | $374,500.00 | -38.3% | |
| Jun 15, 2015 | Bonvini Ezio72 | Senior VP, Research | Sale+OE | 6,233 | $34.01 | $211,984.33 | -14.5% | |
| May 15, 2015 | Bonvini Ezio72 | Senior VP, Research | Sale+OE | 6,233 | $30.24 | $188,485.92 | -14.5% | |
| Apr 15, 2015 | Bonvini Ezio72 | Senior VP, Research | Sale+OE | 6,233 | $33.98 | $211,797.34 | -14.5% | |
| Apr 1, 2015 | Wigginton Jon Marc | Sr VP, Clinical | Sale+OE | 5,000 | $30.86 | $154,300.00 | -100% |